Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials
暂无分享,去创建一个
N. Sato | N. Masumori | H. Kitamura | Toshiaki Tanaka | Y. Hirohashi | T. Torigoe | T. Tsukamoto | Sachiyo Nishida | R. Inoue | Akari Takahashi-Takaya | S. Kawami